From R&D to manufacturing.

Xihong Biopharma focused on regenerative medical devices - from R&D to manufacturing and global sales.We specialize inadvanced biomaterials such as PLLA, PCL, and CaHA, supporting partners with safe, effective, and scalable solutions.Our cleanroom-based smartfacility integrates formulation, filling, capping, andlabeling-all in-house to ensure quality,consistency, and efficiency.

33,000 m² Smart Manufacturing Hub

40+ Granted Patents

10+ Million Doses / Year

Driving Global Innovation in Regenerative Aesthetics

With our Beijing R&D center as the innovation core and a strong global footprint, we lead breakthroughs in regenerative aesthetics and anti-aging.Our integrated innovation system covers research, technology, and large-scale production.We currently have multiple products under international registration, including three world-first innovations — showcasing our competitive edge worldwide.

Expertise in Polymer and Regenerative Biomaterials

We have accumulated rich expertise and proprietary technologies in the R&D, modification and preparation of polymer materials and regenerative biomaterials, the RD and preparation of microsphere.
■ PLLA
■ PCL
■ CaHA
■ PLLA-PEG, etc.
■ HA ■ COL ■ ECM ■ CMC
■ PMMA ■ COLL ■ ECM

Automated Microsphere Preparation System

■ SIP/CIP Sterilization
■ Uniform Particle Size Control
■ High-Throughput Microfluidic Technology
■Meet GMP
■ ISO 13485
■ ISO 9001
Leave a message
First Name*
Last Name*
Email*
Message*